Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
Buspirone and Melatonin Combination for Depression
Recruiting3 awardsPhase 4
Charlestown, Massachusetts
This trial is investigating the effectiveness of a novel treatment combination of Buspirone and Melatonin (B+MEL) in outpatients with clinical depression who have also suffered a traumatic brain injury (TBI). The trial will measure changes in depressive symptoms, cognitive symptoms, and brain activity before and after treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.